Abstract:Fifth AACR International Conference on Frontiers in Cancer Prevention Research, Nov 12-15, 2006 A211 The nicotine-derived tobacco-specific nitrosamine (TSNA), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), is one of-the most potent and abundant pro-carcinogens found in tobacco and tobacco smoke, and glucuronidation of its major metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNAL), by UDP-glucuronosyltransferases (UGTs) is an important mechanism for NNK detoxification. Although several UGTs have been identified as being active NNAL-glucuronidating enzymes, no studies have as yet been performed on UGT2B10, a hepatic enzyme also found in lung. In the present study, we examined the glucuronidation activity of UGT2B10 against NNAL as well as other TSNAs and assessed whether individual UGT2B10 haplotypes are associated with differences in liver microsomal NNAL glucuronidation activities in vitro . HPLC analysis demonstrated that UGT2B10 exhibited significant N -glucuronidating activity against NNAL and other TSNAs. Kinetic analysis demonstrated that UGT2B10-over-expressing cell homogenates exhibits 9.2-fold higher levels of activity against NNAL and between 4-19-fold higher activity against other TSNAs including N'-nitrosonornicotine (NNN), N'-nitrosoanabasine (NAB), and N'-nitrosoanatabine (NAT) as compared to the other known N -glucuronidating enzyme, UGT1A4. Four common (>2% prevalence) haplotypes (termed A , B, C, and D ) were identified in one block of high linkage disequilibrium (LD; D'>0.80) by HapMap screening of the entire UGT2B10 locus, and three haplotype-tagging SNPs were chosen in the present study to distinguish the four haplotypes. The frequencies of haplotypes A, B, C , and D were 63%, 19%, 11%, and 6% in 73 subjects from whom liver specimens were obtained. The C hapalotype was significantly associated with low NNAL N -glucuronidation activity in liver microsomal specimens. Specimens with at least one copy of the C haplotype exhibited a significant ( P <0.001) 44% reduction in NNAL- N -glucuronidation activity as compared to all other subjects. In addition, the C/ C diplotype exhibited a significant ( P <0.001) 11-fold reduction in NNAL- N -glucuronidation activity as compared to subjects without a C haplotype. UGT2B10 expression levels in liver tissues, determined by real time-PCR on cDNA, were not significantly associated with haplotypes. A potentially-functional non-synonomous novel SNP and a synonomous novel SNP were discovered in the UGT2B10 coding region in individuals with a C haplotype. These data suggest that UGT2B10 plays a major role in the glucuronidation and detoxification of a major class of tobacco carcinogens, and that the UGT2B10 haplotype C may be strongly associated with altered TSNA detoxification in smokers.

Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats

Effects of vitamins and common drugs on reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rat microsomes

Characterization of Activation and Deactivation Pathways of 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) in Rat Hepatocytes.

Involvement of P53 Mutation and Mismatch Repair Proteins Dysregulation in NNK-Induced Malignant Transformation of Human Bronchial Epithelial Cells

Analysis of methyl DNA adducts and metabolites in BEAS-2B cells induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

Genetic Variability in the Metabolism of the Tobacco‐specific Nitrosamine 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK) to 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL)

Exposure to Tobacco-Specific Carcinogen NNK in US Population (NHANES 201112): Its Urinary Metabolite NNAL Concentration and Estimated Dose

Assessing Exposure to Tobacco-Specific Carcinogen NNK Using Its Urinary Metabolite NNAL Measured in US Population: 2011–2012

Inhibition of pancreatic acinar mitochondrial thiamin pyrophosphate uptake by the cigarette smoke component 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

The Application of Hepatic P450 Reductase Null Gpt Delta Mice in Studying the Role of Hepatic P450 in Genotoxic Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced Mutagenesis

Detoxification of Tobacco-Specific Nitrosamines in Humans: Association with UGT2B10 Haplotypes.

1H NMR Study of Monocrotaline and Its Metabolites in Human Blood

Glucuronidation Of Tobacco-Specific Nitrosamines By Ugt2b10

[Induction of Pulmonary Precancerous Lesions by Tobacco-Specific NNK in Wistar Rats].

4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone Promoted Gastric Cancer Growth Through Prostaglandin E Receptor (EP2 and EP4) in Vivo and in Vitro

Gender Differences in Mrna Expression of Atp-Binding Cassette Efflux and Bile Acid Transporters in Kidney, Liver, and Intestine of 5/6 Nephrectomized Rats

Metabolic Activation of Retrorsine May Disrupt Bile Acid Homeostasis in Mice Through the Nrf2 Pathway.

Differences in β-naphthylamine metabolism and toxicity in Chinese hamster ovary cell lines transfected with human CYP1A2 and NAT24, NAT25B or NAT2*7B N-acetyltransferase 2 haplotypes

Nicotine Inhibits the Cytotoxicity and Genotoxicity of NNK Mediated by CYP2A13 in BEAS-2B Cells

Hepatic Cytochrome P450s Play A Major Role In Monocrotaline-Induced Renal Toxicity In Mice

Study of the metabolism on tobacco-specific N -nitrosamines in the rabbit by solid-phase extraction and liquid chromatography–tandem mass spectrometry